EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Tumor Effects of Statins in Pancreatic Ductal Adenocarcinoma Cells

Veronika Kucháriková, Zuzana Hatoková, Eva Baranovičová iD, Bibiána Baďurová iD, Tereza Pavlišová, Lucia Kotúľová iD, Michal Kalman, Juraj Marcinek, Oľga Chodelková, Slavomíra Nováková, Ján Strnádel, Henrieta Škovierová iD und 1 weitere

International Journal of Molecular Sciences · 25.03.2026 · 27 (7) · 2972

DOI: 10.3390/ijms27072972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.03.2026. Verfasst von Veronika Kucháriková und 12 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Malá Hora 4C, 036 01 Martin, Slovakia. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Pancreatic Neoplasms, Antineoplastic Agents. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovak Research and Development Agency, Ministry of Education, Research, Development, and Youth of the Slovak Republic, Comenius University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) has limited effective therapeutic strategies. Statins inhibit 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase and may affect tumor cell fitness via the mevalonate pathway, mitochondrial function, and redox homeostasis. We systematically compared seven statins in patient-derived PDAC cell lines and related viability effects to mitochondrial, redox, cell-cycle, apoptotic, and metabolic responses. Statins were tested in three PDAC cell lines (PDAC-1/2/3) using MTT assays (5–20 µM; 24–120 h). Based on MTT responses, mechanistic profiling was performed after 72 h at 20 µM concentration using lipophilic statins, including apoptosis (Annexin V/7-AAD), cell-cycle distribution, mitochondrial membrane potential (Δψm), intracellular ROS, and 1H-NMR quantification of intracellular and extracellular metabolites. Statins reduced viability in a concentration- and time-dependent manner, with lipophilic statins more active than hydrophilic. PDAC-1 was highly sensitive, PDAC-3 intermediate, and PDAC-2 comparatively resistant. PDAC-1 and PDAC-3 showed G0/G1 accumulation, Δψm depolarization, reactive oxygen species (ROS) elevation, and Annexin V–positive apoptosis, whereas PDAC-2 (high basal ROS) showed ROS reduction and limited apoptosis despite Δψm loss. Metabolomics indicated reduced glucose and amino-acid utilization and lactate secretion while preserving line-specific metabolic fingerprints. PDAC cell lines display marked inter-tumoral heterogeneity in statin responses, supporting evaluation of statins as chemosensitizing adjuvants in functionally guided PDAC treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalHydroxymethylglutaryl-CoA Reductase InhibitorsPancreatic NeoplasmsAntineoplastic AgentsHumansApoptosisReactive Oxygen SpeciesMembrane Potential, MitochondrialCell Line, TumorCell SurvivalCell CycleMitochondria

Stichwörter der Autor:innen

pancreatic ductal adenocarcinomapersonalized therapystatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsReactive Oxygen SpeciesAntineoplastic Agents

Autor:innen und Institutionen

  • Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Malá Hora 4C, 036 01 Martin, Slovakia.
  • Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Malá Hora 4D, 036 01 Martin, Slovakia.
  • Department of Pathological Anatomy, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava and University Hospital Martin, Kollárová 2, 036 01 Martin, Slovakia.

ORCID-Profile: Eva Baranovičová, Bibiána Baďurová, Lucia Kotúľová, Henrieta Škovierová

Förderung

  • Slovak Research and Development Agency
  • Ministry of Education, Research, Development, and Youth of the Slovak Republic
  • Comenius University
  • Comenius University in Bratislava

Zitieren

APA

Kucháriková, V., Hatoková, Z., Baranovičová, E., Baďurová, B., Pavlišová, T., Kotúľová, L., Kalman, M., Marcinek, J., Chodelková, O., Nováková, S., Strnádel, J., Škovierová, H., & Halašová, E. (2026). Anti-Tumor Effects of Statins in Pancreatic Ductal Adenocarcinoma Cells. International Journal of Molecular Sciences, 27(7), 2972. https://doi.org/10.3390/ijms27072972

Vancouver

Kucháriková V, Hatoková Z, Baranovičová E, Baďurová B, Pavlišová T, Kotúľová L, et al. Anti-Tumor Effects of Statins in Pancreatic Ductal Adenocarcinoma Cells. International Journal of Molecular Sciences. 2026;27(7):2972. doi:10.3390/ijms27072972

BibTeX
@article{Kuchrikov2026,
  author = {Kucháriková, Veronika and Hatoková, Zuzana and Baranovičová, Eva and Baďurová, Bibiána and Pavlišová, Tereza and Kotúľová, Lucia and Kalman, Michal and Marcinek, Juraj and Chodelková, Oľga and Nováková, Slavomíra and Strnádel, Ján and Škovierová, Henrieta and Halašová, Erika},
  title = {Anti-Tumor Effects of Statins in Pancreatic Ductal Adenocarcinoma Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {2972},
  doi = {10.3390/ijms27072972}
}
Kostenlos starten →